BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Khatri V, Kalyanasundaram R. Therapeutic implications of inflammasome in inflammatory bowel disease. FASEB J 2021;35:e21439. [PMID: 33774860 DOI: 10.1096/fj.202002622R] [Cited by in Crossref: 1] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Yoon B, Yun Y, Kim KB, Kim D. Inhibition of immunoproteasome attenuates NLRP3 inflammasome formation in tumor necrosis factor α-stimulated intestinal epithelial cell. Biochemical and Biophysical Research Communications 2022;624:157-63. [DOI: 10.1016/j.bbrc.2022.07.120] [Reference Citation Analysis]
2 Guo X, Zhang Y, Liu C, Ren L, Gao S, Bi J, Liang J, Wang P. Intranasal administration of β‐1, 3‐galactosyltransferase 2 confers neuroprotection against ischemic stroke by likely inhibiting oxidative stress and NLRP3 inflammasome activation. The FASEB Journal 2022;36. [DOI: 10.1096/fj.202200456rr] [Reference Citation Analysis]
3 Jahan S, Awaja N, Hess B, Hajjar S, Sad S, Lohnes D. The transcription factor Cdx2 regulates inflammasome activity through expression of the NLRP3 suppressor TRIM31 to maintain intestinal homeostasis. J Biol Chem 2022;:102386. [PMID: 35985421 DOI: 10.1016/j.jbc.2022.102386] [Reference Citation Analysis]
4 Bernardazzi C, Castelo-Branco MTL, Pêgo B, Ribeiro BE, Rosas SLB, Santana PT, Machado JC, Leal C, Thompson F, Coutinho-Silva R, de Souza HSP. The P2X7 Receptor Promotes Colorectal Inflammation and Tumorigenesis by Modulating Gut Microbiota and the Inflammasome. Int J Mol Sci 2022;23:4616. [PMID: 35563010 DOI: 10.3390/ijms23094616] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
5 Wang Z, Gao Y, Huang S, Wang J, Zheng N. Ex Vivo and In Vitro Studies Revealed Underlying Mechanisms of Immature Intestinal Inflammatory Responses Caused by Aflatoxin M1 Together with Ochratoxin A. Toxins 2022;14:173. [DOI: 10.3390/toxins14030173] [Reference Citation Analysis]
6 Bauset C, Lis-lopez L, Coll S, Gisbert-ferrándiz L, Macias-ceja DC, Seco-cervera M, Navarro F, Esplugues JV, Calatayud S, Ortiz-masia D, Barrachina MD, Cosín-roger J. SUCNR1 Mediates the Priming Step of the Inflammasome in Intestinal Epithelial Cells: Relevance in Ulcerative Colitis. Biomedicines 2022;10:532. [DOI: 10.3390/biomedicines10030532] [Reference Citation Analysis]
7 Cliff CL, Williams BM, Chadjichristos CE, Mouritzen U, Squires PE, Hills CE. Connexin 43: A Target for the Treatment of Inflammation in Secondary Complications of the Kidney and Eye in Diabetes. Int J Mol Sci 2022;23:600. [PMID: 35054783 DOI: 10.3390/ijms23020600] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
8 Honig G, Larkin PB, Heller C, Hurtado-Lorenzo A. Research-Based Product Innovation to Address Critical Unmet Needs of Patients with Inflammatory Bowel Diseases. Inflamm Bowel Dis 2021;27:S1-S16. [PMID: 34791292 DOI: 10.1093/ibd/izab230] [Reference Citation Analysis]
9 Chen S, Zhang Y, Niu X, Mohyuddin SG, Wen J, Bao M, Yu T, Wu L, Hu C, Yong Y, Liu X, Abd El-Aty AM, Ju X. Coral-Derived Endophytic Fungal Product, Butyrolactone-I, Alleviates Lps Induced Intestinal Epithelial Cell Inflammatory Response Through TLR4/NF-κB and MAPK Signaling Pathways: An in vitro and in vivo Studies. Front Nutr 2021;8:748118. [PMID: 34660669 DOI: 10.3389/fnut.2021.748118] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
10 Hyun CK. Molecular and Pathophysiological Links between Metabolic Disorders and Inflammatory Bowel Diseases. Int J Mol Sci 2021;22:9139. [PMID: 34502047 DOI: 10.3390/ijms22179139] [Cited by in F6Publishing: 6] [Reference Citation Analysis]